This inventor holds 2 USPTO granted patents and 1 EPO patent. Top assignee: Johnson Matthey Public Limited Company. Active years: 2012.
Company Filing History:
Years Active: 2012
Title: Neil Kenneth Thomson: Innovator in Opiate Analgesics
Introduction
Neil Kenneth Thomson is a notable inventor based in West Lothian, GB. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the preparation of opiate analgesics. With a total of 2 patents to his name, Thomson's work has garnered attention in the scientific community.
Latest Patents
Thomson's latest patents focus on the preparation of opiate analgesics through a process of reductive alkylation. This innovative method involves creating compounds of specific formulas, where various chemical groups are manipulated to achieve desired properties. The process utilizes hydrogen and a reductive alkylation catalyst, showcasing Thomson's expertise in chemical synthesis and drug development.
Career Highlights
Thomson is currently associated with Johnson Matthey Public Limited Company, a leader in sustainable technologies and advanced materials. His work at the company emphasizes the importance of innovation in the pharmaceutical industry, particularly in developing effective pain management solutions.
Collaborations
Thomson has collaborated with esteemed colleagues such as Melville Mitchell and George Scott Wilson. These partnerships have likely contributed to the advancement of his research and the successful development of his patented processes.
Conclusion
Neil Kenneth Thomson's contributions to the field of opiate analgesics through his innovative patents reflect his dedication to advancing pharmaceutical science. His work continues to impact the industry positively, paving the way for future developments in pain management.